Skip to main content
Home - European Commission
Svenska
sv
Dialog
Select your language
Български
Čeština
Dansk
Deutsch
Eesti
Ελληνικά
English
Español
Français
Hrvatski
Gaeilge
Italiano
Latviešu
Lietuvių
Magyar
Malti
Nederlands
Polski
Português
Română
Suomi
Slovenčina
Slovenščina
Svenska
Close
Search this website
Sök
Hem
Bo, jobba och resa i EU
Folkhälsa
Humanläkemedel
Humanläkemedel
Alla ämnen
Medicinal products
EU:s folkhälsopolitik
Folkhälsostrategi
State of Health in the EU
Strukturfonderna och folkhälsa
EU i världen
Hälsoindikatorer
Improving health systems
Vård utomlands
European Reference Networks
E-hälsa
Utvärdering av medicinska metoder
Hälso- och sjukvårdspersonal
Health systems performance assessment
Expert Panel on effective ways of investing in health
Hälsofrämjande insatser
Tobak
Kost och fysisk aktivitet
Alkohol
Sociala faktorer och jämlik hälsa
Medical devices
Medical Devices - Sector
Medical Devices - New regulations
Medical Devices - Topics of Interest
Medical Devices - Dialogue between interested parties
Medical Devices - Expert Panels
Medical Devices - EUDAMED
Substances of human origin
Blod, vävnader och organ
Läkemedel
Humanläkemedel
EudraLex
Union Register
Pharmaceutical committee and expert groups
European Medicines Agency (EMA)
Insatser mot sjukdomar
Health security and infectious diseases
European Centre for Disease Prevention and Control (ECDC)
Vaccinationer
Antibiotikaresistens
Folksjukdomar
Cancer
Riskbedömning
Vetenskapliga kommittéer
Endocrine disruptors
Endocrine disruptors
Biocides
Biocides
Nytt på sajten
24 februari 2021
Draft - Questions and Answers Document - Regulation (EU) 536/2014 – Version 3 (February 2021)
11 februari 2021
Agenda - 93rd meeting of the Pharmaceutical Committee (17 and 22 February 2021)
09 februari 2021
Summary record - 92nd meeting of the Pharmaceutical Committee (11 December 2020)
08 februari 2021
Updated - Guidance on the management of clinical trials during the COVID-19 (coronavirus) pandemic
12 januari 2021
The Impact of Biosimilar Competition in Europe - Annual report conducted by on behalf of the European Commission
05 januari 2021
Summary record - 91st meeting of the Pharmaceutical Committee (17 November 2020)
14 december 2020
Summary record - 90th meeting of the Pharmaceutical Committee (21 October 2020)
25 november 2020
Questions and Answers - A Pharmaceutical Strategy for Europe
25 november 2020
Press release - Affordable, accessible and safe medicines for all: the Commission presents a Pharmaceutical Strategy for Europe
25 november 2020
Impact Assessment - Revision of the EU legislation on medicines for children and rare diseases (25 November 2020 - 06 January 2021)
Pages
1
2
3
4
5
6
7
8
9
next ›
last »
Nyhetsbrev
Nyhetsbrev
Nyhetsbrev
Mon, 02/15/2021
EU:s plan mot cancer speglar kommissionen osvikliga engagemang
Nytt på sajten
Draft - Questions and Answers Document - Regulation (EU) 536/2014 – Version 3 (February 2021)
Utlagt
24 februari 2021
Agenda - 93rd meeting of the Pharmaceutical Committee (17 and 22 February 2021)
Utlagt
11 februari 2021
Summary record - 92nd meeting of the Pharmaceutical Committee (11 December 2020)
Utlagt
09 februari 2021
Följ oss på Twitter
Mer
I fokus
Pharmaceutical Strategy for Europe
Revision of the legislation on orphan and paediatric medicines
Notices to stakeholders - Withdrawal of the United Kingdom from the EU
Mer information
Pressmaterial
Videoklipp
Eurobarometrar
Evenemang
Samråd
Publikationer
